[Corrigendum] Baicalin promotes the viability of Schwann cells <em>in vitro</em> by regulating neurotrophic factors

Zuo,Wenpu; Wu,Huayu; Zhang,Kun; Lv,Peizhen; Xu,Fuben; Jiang,Weizhe; Zheng,Li; Zhao,Jinmin

doi:10.3892/etm.2021.11056

February-2022 Volume 23 Issue 2

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

February-2022 Volume 23 Issue 2

Full Size Image

Correction Open Access

[Corrigendum] Baicalin promotes the viability of Schwann cells in vitro by regulating neurotrophic factors

Authors:
- Wenpu Zuo
- Huayu Wu
- Kun Zhang
- Peizhen Lv
- Fuben Xu
- Weizhe Jiang
- Li Zheng
- Jinmin Zhao
View Affiliations / Copyright

Affiliations: Medical and Scientific Research Center, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China, Department of Cell Biology and Genetics, School of Premedical Sciences, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China, Guangxi Key Laboratory of Regenerative Medicine, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China, Department of Pharmacology, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China

Copyright: © Zuo et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Article Number: 133
|
Published online on: December 13, 2021

https://doi.org/10.3892/etm.2021.11056
Expand metrics +

Article

Exp Ther Med 14:[Related article:] 507–514, 2017; DOI: 10.3892/etm.2017.4524

After the publication of the above article, the authors have realized that Figs. 3, 5 and 7 in their paper were published with errors; regarding Fig. 3, the data panel for the ‘2 days, 5 µM baicalin’ experiment was selected incorrectly, whereas with Figs. 5 and 7, an incorrect data panel was selected for the ‘Control, 4 days’ data. These errors arose inadvertently as a consequence of the authors’ misfiling of their data.

Figure 3

Cell viability was measured by fluorescein diacetate staining under a light microscope. RSC96 Schwann cells were incubated with 0 (control), 5, 10 or 20 µM baicalin for 2, 4 and 6 days (magnification, x100; scale bar, 200 µm).

Figure 5

Hematoxylin-eosin staining images showing the morphology of RSC96 SCs cultured in vitro with 0 (control), 5, 10 or 20 µM baicalin for 2, 4 and 6 days (magnification x100; scale bar, 200 µm).

Figure 7

Immunohistochemical staining images revealed the presence of S100β. RSC96 Schwann cells were cultured in vitro with 0 (control), 5, 10 or 20 µM baicalin for 2, 4 and 6 days (magnification x100; scale bar, 200 µm).

The revised versions of Figs. 3, 5 and 7, featuring the corrected data panels for the above-mentioned experiments, are shown opposite. Note that the revised data shown for these Figures do not affect the overall conclusions reported in the paper. The authors apologize to the Editor of Experimental and Therapeutic Medicine and to the readership for any inconvenience caused.